We plan to continue expanding our footprints in India, including producing quality excipients and introducing new products Read more
Hester acquires technology from ICAR – NIHSAD to develop Low Pathogenic Avian Influenza (H9N2 strain) Inactivated Vaccine for poultry Read more
We will maintain a growth rate in the high teens for both (CDMO and API business) in the next few years Read more